AI Pathology Model Validated Across Triple-Negative and HER2+ Breast Cancer Subtypes
kjgeras · x · 2026-07-06
Unlike existing genomic tests primarily designed for HR+/HER2-, this AI test performs effectively across all major breast cancer subtypes, including triple-negative (C-index 0.71) and HER2+ (C-index 0.67). Currently, there are no guideline-supported prognostic or predictive tests for these two subtypes.
More from Research
- 3D ResNet Paper Crosses 3,000 Citations Eight Years After CVPR 2018 — HirokatuKataoka · 2026-09-11
- Jeff Heaton's Intro to the Math of Neural Networks eBook Is Free to Download — blaizedsouza · 2026-09-11
- Mathematician Daniel Litt Launches Problem Repo to Track Human vs AI Progress: 15 Problems, 1 Solved — littmath · 2026-09-11
- Open ECDSA.fail challenge uses AI agents to shrink Shor's-algorithm quantum circuits for Bitcoin keys — StefanoGogioso · 2026-09-11
- Alex Townsend posts 200 open problems in numerical linear algebra for humans and AI agents — IgorCarron · 2026-09-11
- Navier-Stokes, Riemann, P vs NP: what this week's math buzzwords mean for you — koltregaskes · 2026-09-11